Madrigal Pharmaceuticals OverviewMadrigal Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for MDGL.
Quarterly Other Income/Expense
-$1.67M
↓ 127.47% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$4.07M
↓ 85.19% YoY
Trailing 12 months ending Mar 31, 2026